A case for a new paradigm in genetic toxicology testing.
暂无分享,去创建一个
[1] D. Chakravarty,et al. Hyperosmolality in the form of elevated NaCl but not urea causes DNA damage in murine kidney cells. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Moore,et al. High concentrations of sodium chloride induce a "positive" response at the TK locus of L5178Y/TK+/- mouse lymphoma cells. , 1988, Environmental and molecular mutagenesis.
[3] S. Seidel,et al. Profiles of gene expression changes in L5178Y mouse lymphoma cells treated with methyl methanesulfonate and sodium chloride. , 2004, Mutagenesis.
[4] Vernon E Walker,et al. Biomarkers in toxicology and risk assessment: informing critical dose-response relationships. , 2008, Chemical research in toxicology.
[5] 岩崎 民子. SOURCES AND EFFECTS OF IONIZING RADIATION : United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR 2000 Report to the General Assembly, with Scientific Annexes , 2002 .
[6] G. Jenkins,et al. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. , 2007, Cancer research.
[7] J. Barrett,et al. Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells. , 1998, Mutagenesis.
[8] Miller Ja,et al. Chemical carcinogenesis: mechanisms and approaches to its control. , 1971, Journal of the National Cancer Institute.
[9] L. Marnett,et al. Endogenous DNA adducts: potential and paradox. , 1993, Chemical research in toxicology.
[10] Micheline Kirsch-Volders,et al. Indirect mechanisms of genotoxicity. , 2003, Toxicology letters.
[11] Fagen Zhang,et al. Dose-response and operational thresholds/NOAELs for in vitro mutagenic effects from DNA-reactive mutagens, MMS and MNU. , 2009, Mutation research.
[12] P. Mosesso,et al. High-dose-level effects in mutagenicity assays utilizing mammalian cells in culture. , 1988, Mutagenesis.
[13] M. Armstrong,et al. Effects of high osmotic strength on chromosome aberrations, sister-chromatid exchanges and DNA strand breaks, and the relation to toxicity. , 1987, Mutation research.
[14] J. Kleinjans,et al. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity. , 2009, Toxicology letters.
[15] R. Storer,et al. The mouse lymphoma L5178Y Tk+/- cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. , 1997, Mutation research.
[16] Lutz Müller,et al. In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU. , 2009, Mutation research.
[17] An in vitro screening paradigm for extracts of whole foods for detection of potential toxicants. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[18] Lynn H Pottenger,et al. Genetic toxicity assessment: employing the best science for human safety evaluation part VI: when salt and sugar and vegetables are positive, how can genotoxicity data serve to inform risk assessment? , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[19] Melvin E Andersen,et al. Dose-dependent transitions in mechanisms of toxicity. , 2004, Toxicology and applied pharmacology.
[20] Raymond R Tice,et al. Comparison of flow cytometry- and microscopy-based methods for measuring micronucleated reticulocyte frequencies in rodents treated with nongenotoxic and genotoxic chemicals. , 2008, Mutation research.
[21] T. Ushijima,et al. No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[22] J. Bemis,et al. In vivo mutation assay based on the endogenous Pig‐a locus , 2008, Environmental and molecular mutagenesis.
[23] M Younes,et al. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.
[24] J. Bemis,et al. Erythrocyte-based Pig-a gene mutation assay: demonstration of cross-species potential. , 2008, Mutation research.
[25] P. Kasper,et al. Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: experience with pharmaceuticals. , 2000, Mutation research.
[26] Alexei Vazquez,et al. The genetics of the p53 pathway, apoptosis and cancer therapy , 2008, Nature Reviews Drug Discovery.
[27] Raffaella Corvi,et al. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. , 2007, Mutation research.
[28] M. Aardema,et al. Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. , 1999, Mutation research.
[29] Jiri Aubrecht,et al. Toxicogenomics: overview and potential applications for the study of non-covalent DNA interacting chemicals. , 2007, Mutation research.
[30] K. R. Smith,et al. Paracelsus and Goethe: founding fathers of environmental health. , 2000, Bulletin of the World Health Organization.
[31] U. Vogel,et al. A sucrose-rich diet induces mutations in the rat colon. , 2002, Cancer research.
[32] J. Swenberg,et al. Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues. , 1999, Cancer research.
[33] D. Eastmond,et al. Detection of micronuclei, cell proliferation and hyperdiploidy in bladder epithelial cells of rats treated with o-phenylphenol. , 2002, Mutagenesis.
[34] Melvin E Andersen,et al. Dose-dependent transitions in mechanisms of toxicity: case studies. , 2004, Toxicology and applied pharmacology.
[35] Alan R. Boobis,et al. IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans , 2006 .